The ubiquitin-proteasome system and its role in ethanol-induced disorders

Addiction Biology

Volumn 7, Issue 1, 2002, Pages 15-28

  Donohue Jr , Terrence M ^a,b  

^a UNIVERSITY OF NEBRASKA MEDICAL CENTER   (United States)

^b VA NEBRASKA WESTERN IOWA HEALTH CARE SYSTEM   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALCOHOL; CYTOCHROME P450 1A; CYTOCHROME P450 2B; CYTOCHROME P450 2E1; CYTOCHROME P450 3A; PROTEASOME; UBIQUITIN;

ALCOHOL ABUSE; ALCOHOL CONSUMPTION; ALCOHOL METABOLISM; ALCOHOLISM; BRAIN METABOLISM; HEART MUSCLE METABOLISM; HUMAN; METABOLIC REGULATION; NONHUMAN; OXIDATIVE STRESS; PATHOPHYSIOLOGY; PRIORITY JOURNAL; REVIEW;

ALCOHOL AMNESTIC DISORDER; ALCOHOL-RELATED DISORDERS; ANIMALS; CARDIOMYOPATHY, ALCOHOLIC; CYSTEINE ENDOPEPTIDASES; ETHANOL; HUMANS; MULTIENZYME COMPLEXES; PROTEASOME ENDOPEPTIDASE COMPLEX; UBIQUITIN;

EID: 0036150886     PISSN: 13556215     EISSN: None     Source Type: Journal    
DOI: 10.1080/135562101200100562     Document Type: Review

References (127)

1. The 26 S Proteasome: A molecular machine designed for controlled proteolysis
2. The proteasome
3. The proteasome, a novel protease regulated by multiple mechanisms
4. The ubiquitin system
5. The ubiquitin system
6. Lysosomes revisited
7. Studies on the mechanisms of autophagy: Formation of the autophagic vacuole
8. Studies on the mechanisms of autophagy: Maturation of the autophagic vacuole
9. When lysosomes get old
10. Ubiquitin-protein conjugates accumulate in the lysosomal system of fibroblasts treated with cysteine proteinase inhibitors
11. Isolation of a polypeptide that has lymphocyte-differentiating properties and is probably represented universally in living cells
12. Isopeptide linkage between nonhistone and histone 2A polypeptides of chromosomal conjugate-protein A24
13. Amino-terminal sequence identity of ubiquitin and the nonhistone component of nuclear protein A24
14. A soluble ATP-dependent proteolytic system responsible for the degradation of abnormal proteins in reticulocytes
15. Characterization of the heat-stable polypeptide of the ATP-dependent proteolytic system from reticulocytes
16. Proposed role of ATP in protein breakdown: Conjugation of protein with multiple chains of the polypeptide of ATP-dependent proteolysis
17. Stimulation of ATP-dependent proteolysis requires ubiquitin with the COOH-terminal sequence Arg-Gly-Gly
18. Release of a macromolecular protein component from human erythrocyte ghosts
19. Cation-sensitive neutral endopeptidase: Isolation and specificity of the bovine pituitary enzyme
20. A multicatalytic protease complex from pituitary that forms enkephalin and enkephalin containing peptides
21. The quaternary structure of carp muscle aklaline protease
22. The 22 S cylinder particles of Xenopus laevis. I. Biochemical and electron microscopic characterization
23. Purification and characterization of a multicatalytic high-molecular-mass proteinase from rat skeletal muscle
24. Purification of a liver alkaline protease which degrades oxidatively modified glutamine synthetase. Characterization as a high molecular weight cysteine proteinase
25. Identity of the 19S "prosome" particle with the large multifunctional protease complex of mammalian cells (the proteasome)
26. Drosophila small cytoplasmic 19S ribonucleoprotein is homologous to the rat multicatalytic proteinase
27. Displacement of housekeeping proteasome subunits by MHC-encoded LMPs: A newly discovered mechanism for modulating the multicatalytic proteinase complex
28. Antigen presentation by MHC class I and its regulation by interferon gamma
29. Evidence for the presence of five distinct proteolytic components in the pituitary multicatalytic proteinase complex. Properties of two components cleaving bonds on the carboxyl side of branched chain and small neutral amino acids
30. Catalytic components of the bovine pituitary multicatalytic proteinase complex (proteasome)
31. Effects of chronic ethanol administration on rat liver proteasome activities: Relationship with oxidative stress
32. NADPH-dependent microsomal electron transfer increases degradation of CYP2E1 by the proteasome complex: Role of reactive oxygen species
33. The proteasome: A macromolecular assembly designed to confine proteolysis to a nanocompartment
34. Pathways of ubiquitin conjugation
35. Introduction: Evolving roles for ubiquitin in cellular regulation
36. Multiple forms of the 20 S multicatalytic and the 26 S ubiquitin/ATP- dependent proteases from rabbit reticulocyte lysate
37. Ubiquitin and the enigma of intracellular protein degradation
38. Ubiquitination and deubiquitination: Targeting of proteins for degradation by the proteasome
39. Ubiquitin and proteasome-dependent pathway of protein degradation as an emerging therapeutic target
40. Proteasome inhibition: A new strategy in cancer treatment
41. Ubiquitin is a common factor in intermediate filament inclusion bodies of diverse type in man, including those of Parkinson's disease, Pick's disease, and Alzheimer's disease, as well as Rosenthal fibres in cerebellar astrocytomas, cytoplasmic bodies in muscle, and mallory bodies in alcoholic liver disease
42. Ubiquitin, cellular inclusions and their role in neurodegeneration
43. Ubiquitin immunochemistry as a diagnostic aid for community pathologists evaluating patients who have dementia
44. Frameshift mutants of beta amyloid precursor protein and ubiquitin-B in Alzheimer's and Down patients
45. Inhibition of the ubiquitin-proteasome system in Alzheimer's disease
46. Amyloid beta-protein inhibits ubiquitin-dependent protein degradation in vitro
47. Impaired proteasome function in Alzheimer's disease
48. Proteasomal function is impaired in substantia nigra in Parkinson's disease
49. Sepsis stimulates nonlysosomal, energy-dependent proteolysis and increases ubiquitin mRNA levels in rat skeletal muscle
50. Activation of the ubiquitin-ATP-dependent proteolytic system in skeletal muscle during fasting and denervation atrophy
51. Metabolic acidosis stimulates muscle protein degradation by activating the adenosine triphosphate-dependent pathway involving ubiquitin and proteasomes
52. Ubiquitin gene expression is increased in skeletal muscle of tumour-bearing rats
53. Role of different proteolytic systems in the degradation of muscle proteins during denervation atrophy
54. Burn injury upregulates the activity and gene expression of the 20 S proteasome in rat skeletal muscle
55. Sensitivity and protein turnover response to glucocorticoids are different in skeletal muscle from adult and old rats. Lack of regulation of the ubiquitin-proteasome proteolytic pathway in aging
56. Interleukin-6 induces proteolysis by activating intracellular proteases (cathepsins B and L, proteasome) in C2C12 myotubes
57. Natural substrates of the ubiquitin proteolytic pathway
58. Role of the ubiquitin-proteasome pathway in regulating abundance of the cyclin-dependent kinase inhibitor p27
59. Cyclin is degraded by the ubiquitin pathway
60. The ubiquitin-proteasome proteolytic pathway
61. The ubiquitin system for protein degradation
62. Proteolysis in cultured liver epithelial cells during oxidative stress. Role of the multicatalytic proteinase complex, proteasome
63. Postanoxic formation of aldehydic lipid peroxidation products in human renal tubular cells
64. Increased levels of 4-hydroxynonenal modified proteins in plasma of children with autoimmune diseases
65. Peroxynitrite increases the degradation of aconitase and other cellular proteins by proteasome
66. ER degradation of a misfolded luminal protein by the cytosolic ubiquitin-proteasome pathway
67. The abnormal isoform of the prion protein accumulates in late-endosome-like organelles in scrapie-infected mouse brain
68. Effect of chronic ethanol feeding on lipid peroxidation and protein oxidation in relation to liver pathology
69. Alcoholic hepatomegaly: Accumulation of protein in the liver
70. Pathogenesis of alcohol-induced accumulation of protein in the liver
71. Effect of chronic ethanol administration on protein catabolism in rat liver
72. Inhibition of proteolysis in the liver by chronic ethanol feeding
73. Ethanol administration alters the proteolytic activity of hepatic lysosomes
74. Ethanol consumption reduces the proteolytic capacity and protease activities of hepatic lysosomes
75. Ethanol consumption alters trafficking of lysosomal enzymes and affects the processing of procathepsin L in rat liver
76. Serum ubiquitin levels in patients with alcoholic liver disease
77. Effects of ethanol administration on components of the ubiquitin proteolytic pathway in rat liver
78. Peptidase activities of the multicatalytic protease in rat liver after voluntary and intragastric ethanol administration
79. Severe and progressive steatosis and focal necrosis in rat liver induced by continuous intragastric infusion of ethanol and low fat diet
80. Ethanol oxidation by hepatic microsomes: Adaptive increase after ethanol feeding
81. New pathway of ethanol metabolism in the liver
82. Hepatic microsomal ethanol oxidizing system (MEOS): Differentiation from alcohol dehydrogenase and NADPH oxidase
83. Chlormethiazole inhibition of cytochrome P450 2E1 as assessed by chlorzoxazone hydroxylation in humans
84. Inhibition of ethanol-induced liver disease in the intragastric feeding rat model by chlormethiazole
85. The effect of ethanol-induced cytochrome p4502E1 on the inhibition of proteasome activity by alcohol
86. CYP2E1 is not involved in early alcohol-induced liver injury
87. Acetaldehyde adducts with proteins: Binding of [14C]acetaldehyde to serum albumin
88. Covalent binding of acetaldehyde selectively inhibits the catalytic activity of lysine-dependent enzymes
89. Formation of acetaldehyde adducts with ethanol-inducible P450IIE1 in vivo
90. CYP2E1-mediated oxidative stress induces collagen type I expression in rat hepatic stellate cells
91. Role of CYP2E1 in the pathogenesis of alcoholic liver disease: Modifications by cAMP and ubiquitin-proteasome pathway
92. Ethanol cytotoxicity to a transfected HepG2 cell line expressing human cytochrome P4502E1
93. Ethanol induces CYP2E1 by protein stabilization. Role of ubiquitin conjugation in the rapid degradation of CYP2E1
94. Use of reverse transcription-polymerase chain reaction to evaluate in vivo cytokine gene expression in rats fed ethanol for long periods
95. Inhibition of the proteasome as a therapeutic approach
96. Acetaldehyde prevents nuclear factor-kappa B activation and hepatic inflammation in ethanol-fed rats
97. The chemistry of acetaldehyde-protein adducts
98. Acetaldehyde and malondialdehyde react together to generate distinct protein adducts in the liver during long-term ethanol administration
99. Inhibitory effect of nonenzymatic glycation on ubiquitination and ubiquitin-mediated degradation of lysozyme
100. Lactacystin, a specific inhibitor of the proteasome, induces apoptosis and activates caspase-3 in cultured cerebellar granule cells
101. Peptidyl aldehyde inhibitors of proteasome induce apoptosis rapidly in mouse lymphoma RVC cells
102. The role of the ubiquitin-proteasome pathway in apoptosis
103. Proteasomes play an essential role in thymocyte apoptosis
104. Chronic ethanol feeding increases apoptosis and cell proliferation in rat liver
105. Oxidative stress-mediated apoptosis of hepatocytes exposed to acute ethanol intoxication
106. Ethanol-induced apoptosis in vitro
107. NGF-differentiated and undifferentiated PC12 cells vary in induction of apoptosis by ethanol
108. Effect of oxidant systems on the ubiquitylation of proteins in the central nervous system
109. Oxidative stress increases ubiquitin-protein conjugates in synaptosomes
110. The ubiquitin-proteasome proteolytic pathway in heart vs skeletal muscle: Effects of acute diabetes
111. The gap junction protein connexin43 is degraded via the ubiquitin proteasome pathway
112. Enzymes catalysing ethanol metabolism in neural and somatic tissues of the rat
113. Induction of brain cytochrome P-450IIE1 by chronic ethanol treatment
114. Ethanol metabolism in the brain
115. Molecular mechanism of ethanol metabolism by human brain to fatty acid ethyl esters
116. Formation of fatty acid ethyl esters during chronic ethanol treatment in mice
117. Metabolism of ethanol by human brain to fatty acid ethyl esters
118. Fatty acid ethyl esters are present in human serum after ethanol ingestion
119. Identification of fatty acid ethyl esters as products of rabbit myocardial ethanol metabolism
120. Mitochondrial dysfunction induced by fatty acid ethyl esters, myocardial metabolites of ethanol
121. Mechanism of fatty acid ethyl ester formation and biological significance
122. In vitro activation of the 20S proteasome
123. Neurofibrillary tangles in progressive supranuclear palsy brains exhibit immunoreactivity to frameshift mutant ubiquitin-B protein
124. Skeletal muscle and liver contain a soluble ATP + ubiquitin-dependent proteolytic system
125. Effect of chronic coadministration of endotoxin and ethanol on rat liver pathology and proinflammatory and anti-inflammatory cytokines